Jonathan E. Kolitz
Jonathan E. Kolitz publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research and Acute Lymphoblastic Leukemia research.
- World rank
- #185,721 of 7,710,434 ranked researchers
- Rank in United States
- #69,214 of 1,627,098
- Works
- 471
- Citations
- 24k
- Citations per work
- 51.9
What does Jonathan E. Kolitz research?
Jonathan E. Kolitz's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences26255.6%
- Medicine26255.6%
- Life Sciences11324.0%
- Everything else9620.4%
- 1Hematology29% of their works
- 2Genetics15% of their works
- 3Molecular Biology14% of their works
- 4Immunology10% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Oncology5% of their works
Research topics
- Acute Myeloid Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Acute Lymphoblastic Leukemia research
- Chronic Myeloid Leukemia Treatments
- Immunodeficiency and Autoimmune Disorders
- Lymphoma Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Monoclonal and Polyclonal Antibodies Research
Which keywords describe Jonathan E. Kolitz's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Acute Lymphoblastic Leukemia and Childhood Cancer.
- Therapeutic Antibodies
- Myelofibrosis
- Lymphoma
- Primary Immunodeficiency
- Imatinib
- Childhood Cancer
- Genomic Aberrations
- Rituximab
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Acute Lymphoblastic Leukemia
- BCR-ABL
- Genetic Mutations
- Classification
- JAK2 Mutation
- Fc Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Prognostic Factors4723 topics
- AML2561 topic
- Acute Myeloid Leukemia2561 topic
- Rituximab1942 topics
- Chronic Lymphocytic Leukemia1361 topic
- Genomic Aberrations1361 topic
- Acute Lymphoblastic Leukemia801 topic
- Childhood Cancer801 topic
- BCR-ABL761 topic
- Imatinib761 topic
- Genetic Mutations591 topic
- Primary Immunodeficiency591 topic
- Classification581 topic
- Lymphoma581 topic
- JAK2 Mutation531 topic
- Myelofibrosis531 topic
- Fc Receptors391 topic
- Therapeutic Antibodies391 topic
Where does Jonathan E. Kolitz work?
Jonathan E. Kolitz's main affiliation in the publication record is Northwell Health, United States.
How many publications and citations does Jonathan E. Kolitz have?
OpenAlex counts 471 works and 24,455 citations for Jonathan E. Kolitz, an h-index of 78, ranking #185,721 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jonathan E. Kolitz. Posts are plain text and can be reported.